{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:18:09Z","timestamp":1786648689284,"version":"build-2736575974"},"reference-count":30,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6,1]]},"DOI":"10.1210\/jc.2013-3919","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T07:10:02Z","timestamp":1394435402000},"page":"1999-2007","source":"Crossref","is-referenced-by-count":80,"title":["A Prospective, Randomized Trial of Intravenous Glucocorticoids Therapy With Different Protocols for Patients With Graves' Ophthalmopathy"],"prefix":"10.1210","volume":"99","author":[{"given":"Wei","family":"Zhu","sequence":"first","affiliation":[{"name":"Shanghai Key Laboratory for Endocrine Tumors (W.Z., L.Y., L.S., F.H., R.H., X.Z., S.W., W.W., G.N.), Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases and Shanghai E-institute for Endocrinology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, P. R. China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Endocrine Tumors (W.Z., L.Y., L.S., F.H., R.H., X.Z., S.W., W.W., G.N.), Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases and Shanghai E-institute for Endocrinology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, P. R. China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Shen","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Endocrine Tumors (W.Z., L.Y., L.S., F.H., R.H., X.Z., S.W., W.W., G.N.), Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases and Shanghai E-institute for Endocrinology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, P. R. China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology (Q.J.), Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, P. R. China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Huang","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Endocrine Tumors (W.Z., L.Y., L.S., F.H., R.H., X.Z., S.W., W.W., G.N.), Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases and Shanghai E-institute for Endocrinology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, P. R. China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulai","family":"Han","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Endocrine Tumors (W.Z., L.Y., L.S., F.H., R.H., X.Z., S.W., W.W., G.N.), Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases and Shanghai E-institute for Endocrinology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, P. R. China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Endocrine Tumors (W.Z., L.Y., L.S., F.H., R.H., X.Z., S.W., W.W., G.N.), Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases and Shanghai E-institute for Endocrinology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, P. R. China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Endocrine Tumors (W.Z., L.Y., L.S., F.H., R.H., X.Z., S.W., W.W., G.N.), Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases and Shanghai E-institute for Endocrinology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, P. R. China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Endocrine Tumors (W.Z., L.Y., L.S., F.H., R.H., X.Z., S.W., W.W., G.N.), Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases and Shanghai E-institute for Endocrinology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, P. R. China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Endocrine Tumors (W.Z., L.Y., L.S., F.H., R.H., X.Z., S.W., W.W., G.N.), Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases and Shanghai E-institute for Endocrinology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, P. R. China;"},{"name":"Laboratory for Endocrine and Metabolic Diseases of Institute of Health Science (G.N.), Shanghai JiaoTong University School of Medicine and Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200025, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113481036000_B1","first-page":"168","article-title":"Management of Graves' ophthalmopathy: reality and perspectives","volume":"21","author":"Bartalena","year":"2000","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113481036000_B2","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1210\/jc.2009-0376","article-title":"Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis","volume":"94","author":"Stiebel-Kalish","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113481036000_B3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1043-2760(02)00622-7","article-title":"Graves' ophthalmopathy: a rational approach to treatment","volume":"13","author":"Wiersinga","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113481036000_B4","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2003-030260","article-title":"Long-term safety of orbital radiotherapy for Graves' ophthalmopathy","volume":"88","author":"Marcocci","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113481036000_B5","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2003.12.054","article-title":"Orbital irradiation for Graves' ophthalmopathy: is it safe? A long-term follow-up study","volume":"111","author":"Wakelkamp","year":"2004","journal-title":"Ophthalmology"},{"key":"key\n\t\t\t\t2019041113481036000_B6","first-page":"3562","article-title":"Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study","volume":"86","author":"Marcocci","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113481036000_B7","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","article-title":"Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy","volume":"90","author":"Kahaly","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113481036000_B8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.1987.tb00836.x","article-title":"Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study","volume":"27","author":"Marcocci","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113481036000_B9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO","volume":"158","author":"Bartalena","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113481036000_B10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/105072504774193276","article-title":"Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy","volume":"14","author":"Marin\u00f3","year":"2004","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113481036000_B11","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","article-title":"Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy","volume":"97","author":"Bartalena","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113481036000_B12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0028-1128141","article-title":"Effect of combined intravenous glucocorticoids and orbital radiotherapy in restoring driving competency in patients with Graves' orbitopathy","volume":"41","author":"Sterker","year":"2009","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041113481036000_B13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2010-1962","article-title":"Clinical review: intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity","volume":"96","author":"Zang","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113481036000_B14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113481036000_B15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jcem-44-1-203","article-title":"Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association","volume":"44","author":"Werner","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113481036000_B16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.eye.6701925","article-title":"Exophthalmos of patients with Graves' disease in Chinese of Taiwan","volume":"20","author":"Tsai","year":"2006","journal-title":"Eye (Lond)"},{"key":"key\n\t\t\t\t2019041113481036000_B17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.2005.02345.x","article-title":"Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial","volume":"63","author":"Wakelkamp","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113481036000_B18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/EJE-07-0558","article-title":"Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study","volume":"158","author":"van Geest","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113481036000_B19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/02713680601186698","article-title":"The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy","volume":"32","author":"Lacka","year":"2007","journal-title":"Curr Eye Res"},{"key":"key\n\t\t\t\t2019041113481036000_B20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2249.2010.04191.x","article-title":"Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions","volume":"161","author":"Vannucchi","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t2019041113481036000_B21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/jc.2005-1689","article-title":"Interferon-\u03b3-inducible \u03b1-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-\u03b3 agonists","volume":"91","author":"Antonelli","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113481036000_B22","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1210\/jc.2008-2450","article-title":"Monokine induced by interferon \u03b3 (IFN\u03b3) (CXCL9) and IFN\u03b3 inducible T-cell \u03b1-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-\u03b3 agonists","volume":"94","author":"Antonelli","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113481036000_B23","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1089\/thy.2009.0069","article-title":"Cardiovascular and cerebrovascular events in temporal relationship to intravenous glucocorticoid pulse therapy in patients with severe endocrine ophthalmopathy","volume":"19","author":"Lendorf","year":"2009","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113481036000_B24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/thy.2000.10.521","article-title":"Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease","volume":"10","author":"Weissel","year":"2000","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113481036000_B25","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113481036000_B26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1468-1331.2006.01097.x","article-title":"Intractable hiccups induced by high-dose intravenous methylprednisolone in a patient with multiple sclerosis","volume":"13","author":"Iijima","year":"2006","journal-title":"Eur J Neurol"},{"key":"key\n\t\t\t\t2019041113481036000_B27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1212\/WNL.11.2.109","article-title":"Effect of adrenocortical hormones on evoked potentials in the brain stem","volume":"11","author":"Feldman","year":"1961","journal-title":"Neurology"},{"key":"key\n\t\t\t\t2019041113481036000_B28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01262730","article-title":"Adrenocorticoids control 5-hydroxytryptamine metabolism in rat brain","volume":"42","author":"Rastogi","year":"1978","journal-title":"J Neural Transm"},{"key":"key\n\t\t\t\t2019041113481036000_B29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-13-0611","article-title":"The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor","volume":"170","author":"Vannucchi","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113481036000_B30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1089\/jop.2005.21.328","article-title":"Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome","volume":"21","author":"Hart","year":"2005","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/6\/1999\/9047999\/jcem1999.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T04:54:53Z","timestamp":1565240093000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/6\/1999\/2537596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,1]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-3919","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,1]]}}}